Publications
5600 Results
- Journal / Conference
- Journal of Clinical Oncology, Apr 10;34(11):1182-1189
- Year
- 2016
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID26858337
- PMC
- PMC4933130
- Study Number(s)
- SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Determinants of early mortality among 37,568 patients with colon cancer who participated in 25 clinical trials from the Adjuvant Colon Cancer Endpoints Database
- Journal / Conference
- Pharmacogenetics and Genomics, Mar;26(3):133-137
- Year
- 2016
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID26658227
- PMC
- PMC4738010
- Study Number(s)
- CTSU/N0147
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)
- Journal / Conference
- American Association for Cancer Research Annual Meeting (2016, April 16-20, New Orleans, LA), poster session, abst #CT125
- Year
- 2016
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1404
A phase III randomized trial comparing FDA approved standard of care adjuvant therapy to one year of pembrolizumab in patients with high risk resected melanoma SWOG 1404
- Journal / Conference
- Annals of Oncology vol. 27, 2016 Supp 6, abst. 754P; European Society for Medical Oncology (October 7-11, 2016, Copenhagen, Denmark), poster
- Year
- 2016
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0421
Bone biomarkers and overall survival (OS) in men with castration resistant prostate cancer (CRPC) and skeletal metastases: updated results from SWOG 0421, a phase III trial of docetaxel +/- atrasentan
- Journal / Conference
- Cancer Research Apr 15;76(8):2288-2300; 2016 Feb 26 [Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID26921328
- PMC
- PMC4873385
- Study Number(s)
- SWOG-9217
A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate risk
- Journal / Conference
- Journal of Clinical Oncology 34, 2016 (suppl; abstr 3597); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), poster session
- Year
- 2016
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Blood-Based Biomarkers in Patients (pts) with Metastatic Colorectal Cancer (mCRC) Treated with FOLFOX or FOLFIRI + Bevacizumab (Bev), Cetuximab (Cetux), or Bev + Cetux: Results from CALGB 80405 (Alliance)
- Journal / Conference
- Nature Communications 2016 Apr 7;7:10979. doi: 10.1038/ncomms10979
- Year
- 2016
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID27052111
- PMC
- PMC4829663
- Study Number(s)
- S0000
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
- Journal / Conference
- Oncotarget 2016 Oct 11;7(41):66328-66343; 2016 Aug 1[Epub ahead of print]
- Year
- 2016
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID27579533
- PMC
- PMC5340084
- Study Number(s)
- S0000
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21
- Journal / Conference
- Leukemia & Lymphoma Feb;58(2):461-465; 2016 Jul 7:1-5. [Epub ahead of print] [print in 2017]
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27386786
- PMC
- PMC5130311
- Study Number(s)
- S0816